No significant difference in DVT incidence between aspirin vs rivaroxaban in total knee arthroplasty
Venous thromboembolism prophylaxis after total knee arthroplasty (TKA): aspirin vs. rivaroxabanRev Bras Ortop. 2017 Dec 6;53(1):22-27
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
32 patients scheduled for total knee arthroplasty were randomized to thromboprophylaxis with either rivaroxaban 10mg daily or aspirin 300mg daily for 14 days after surgery. Patients were assessed for deep vein thrombosis rate, local complication rate, systemic complication rate, reoperation rate, mortality rate, postoperative blood loss, and hemoglobin and hematocrit drop. Of primary consideration...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE